 |
市場調查報告書
商品編碼
1427264
全球神經診斷市場規模、佔有率、成長分析，按病理、最終用戶- 2023-2030年產業預測Global Neurodiagnostics Market Size, Share, Growth Analysis, By Condition(Neuro Degenerative Diseases, Epilepsy), By End User(Hospitals & Surgery Centers, Diagnostic Laboratories & Imaging Centers) - Industry Forecast 2023-2030 |
||||||
2022年全球神經診斷市場規模預計為74.5億美元，從2023年的79.7億美元成長到2031年的136.9億美元，預測期內（2024-2031年）年複合成長率為7%。
神經診斷市場對於醫療保健專業人員診斷、監測和製定神經系統疾病的治療計劃非常重要。可以了解大腦和神經系統的功能、識別異常並制定適當的治療策略。神經診斷程序包括各種測試，如腦電圖（EEG）、肌電圖（EMG）、神經影像技術（MRI、 電腦斷層掃描）和專門評估，所有這些都可以提供神經系統狀況的寶貴見解。神經診斷市場背後的驅動力是全球神經系統疾病數量的增加。阿茲海默症、癲癇和多發性硬化症等疾病正變得越來越常見，這凸顯了對準確有效的診斷工具的需求。該市場面臨的挑戰包括神經系統疾病的複雜性，通常需要多種診斷方法才能進行準確評估。解釋神經診斷測試的結果也很困難，需要專業知識和先進的資料分析技術。儘管面臨挑戰，神經診斷市場仍提供了巨大的機會。人工智慧（AI）和機器學習等技術進步是提高診斷準確性和效率的有希望的手段。遠端醫療和遠端監控功能的集合成為遠端神經診斷鋪平了道路，確保即使在服務不足的地區也能獲得專門護理。最終，全球神經診斷市場透過促進神經系統疾病的診斷和監測來為醫療保健專業人員提供服務。儘管成本和監管等障礙仍然存在，但技術創新、遠端監控和研究合作等機會促進市場的成長和加強。
使用自上而下和自下而上的方法，估計並檢驗了全球神經診斷市場規模，並估計了其他各個相關子市場的市場規模。用於估計市場規模的調查方法包括以下詳細資訊：用於確定市場主要企業的二次研究，用於確定每個地區的市場佔有率的主要和二次研究。整個過程包括研究主要企業的年度和財務報告以及廣泛的採訪，以獲得執行長、副總裁、董事和行銷負責人等行業領導者的重要見解。所有股份比率和細分均使用二手資訊確定並使用主要資訊檢驗。本研究涵蓋的所有可能影響市場的參數都經過考慮、詳細研究、經過初步研究檢驗，並進行分析以獲得最終的定量和定性資料。
全球神經診斷市場細分分析
全球神經診斷市場根據病理、最終用戶和地區進行細分。就病理而言，市場分為神經退化性疾病、癲癇、中風、頭痛疾病、睡眠障礙等。依最終用戶細分，市場分為醫院和手術中心、診斷實驗室和影像中心、神經學中心等。依地區分類，分為北美、歐洲、亞太地區、中東、非洲、拉丁美洲。
全球神經診斷市場的促進因素
阿茲海默症、帕金森氏症和癲癇等神經系統疾病的上升趨勢是推動神經診斷市場向前發展的關鍵因素。由於世界老化和生活方式的改變，神經系統疾病的發生率不斷上升，導致對用於診斷和監測目的的精確神經診斷的需求增加。
腦電圖設備、肌電圖（EMG）設備和神經影像設備等神經診斷設備的進步繼續推動市場擴張。這些技術進步增強了功能、提高了準確性並提高了患者的舒適度。此類先進設備的存在鼓勵醫療保健提供者購買神經診斷設備，並刺激市場成長。
全球神經診斷設備市場的限制因素
與神經診斷程序相關的高成本可能會阻礙市場成長。這些手術通常需要昂貴的設備、專門的測試和熟練的醫務人員。這些成本可能會限制獲得這些治療的機會，特別是在低收入和中等收入國家，並阻礙市場擴張。
神經診斷領域必須遵守嚴格的監管標準和合規通訊協定。新的神經診斷設備和技術獲得監管部門的批准需要漫長而昂貴的努力。這些監管障礙可能會阻礙創新和新產品的推出，阻礙市場擴張。
全球神經診斷市場趨勢
將資料分析和雲端運算融入神經診斷中變得越來越普遍。在雲端儲存和分析大量患者資料可以簡化資料管理、遠端協作以及創建支援診斷和治療策略的預測模型。這種轉變鼓勵在神經診斷中使用資料驅動的方法和個人化護理。
目錄
- 執行摘要
- 調查方法
- 母市場分析
- 主要市場考察
- 技術分析
- 價格分析
- 供應鏈分析
- 價值鏈分析
- 市場生態系統
- 智慧財產權分析
- 貿易分析
- Start-Ups分析
- 原料分析
- 創新矩陣
- 研發線產品分析
- 總體經濟指標
- 主要投資分析
- 關鍵成功因素
- 競爭程度
- 市場動態及展望
- 市場動態
- 促進因素
- 機會
- 抑制因素
- 課題
- 監管形勢
- 波特的分析
- 對未來顛覆的特別見解
- 市場動態
- 全球神經診斷市場：依病理狀態分類
- 市場概況
- 神經退化性疾病
- 癲癇
- 中風
- 頭痛症
- 睡眠失調
- 其他
- 全球神經診斷市場：依最終用戶分類
- 市場概況
- 醫院及手術中心
- 診斷實驗室和影像中心
- 神經中樞
- 其他
- 全球神經診斷市場規模：依地區
- 市場概況
- 北美洲
- 美國
- 加拿大
- 歐洲
- 德國
- 西班牙
- 法國
- 英國
- 其他歐洲國家地區
- 亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
- 拉丁美洲
- 巴西
- 其他拉丁美洲地區
- 中東和非洲（MEA）
- 海灣合作理事會國家
- 南非
- 其他中東、非洲地區
- 競爭形勢
- 前5名企業對比
- 主要企業市場定位（2021年）
- 主要市場參與者所採取的策略
- 關鍵成功策略
- 近期市集活動
- 主要企業市場佔有率（2021年）
- 主要企業簡介
- Siemens Healthineers（Germany）
- GE Healthcare（US）
- Philips Healthcare（Netherlands）
- Medtronic（Ireland）
- Hitachi Medical Corporation（Japan）
- Natus Medical Incorporated（US）
- Abbott Laboratories（US）
- Koninklijke Philips NV（Netherlands）
- Thermo Fisher Scientific Inc.（US）
- Elekta AB（Sweden）
- Brainlab AG（Germany）
- Masimo Corporation（US）
- Cadwell Industries Inc.（US）
- Advanced Brain Monitoring, Inc.（US）
- Compumedics Limited（Australia）
- Neurosoft Ltd.（Russia）
- Magstim（UK）
- NeuroWave Systems Inc.（US）
- BrainScope Company Inc.（US）
- Blackrock Microsystems LLC（US）
Global Neurodiagnostics Market size was valued at USD 7.45 Billion in 2022 and is poised to grow from USD 7.97 Billion in 2023 to USD 13.69 Billion by 2031, at a CAGR of 7% during the forecast period (2024-2031).
The neurodiagnostics market is essential for aiding healthcare professionals in diagnosing, monitoring, and planning treatment for neurological disorders. It enables them to comprehend brain and nervous system functioning, identify irregularities, and devise appropriate treatment strategies. Neurodiagnostic procedures encompass various tests like electroencephalography (EEG), electromyography (EMG), neuroimaging techniques (MRI, CT scan), and specialized assessments, all providing valuable insights into neurological conditions. A driving force behind the neurodiagnostics market is the global increase in neurological disorder prevalence. Conditions like Alzheimer's disease, epilepsy, and multiple sclerosis are becoming more common, highlighting the necessity for precise and effective diagnostic tools. Challenges in this market include the intricate nature of neurological disorders, often requiring multiple diagnostic methods for accurate evaluations. Interpreting neurodiagnostic test results also poses difficulties, demanding specialized knowledge and advanced data analysis techniques. Despite challenges, the neurodiagnostics market offers substantial opportunities. Technological advancements such as artificial intelligence (AI) and machine learning hold promise for enhancing diagnostic accuracy and efficiency. Integration of telemedicine and remote monitoring capabilities creates avenues for remote neurodiagnostics, ensuring access to specialized care in underserved regions. Ultimately, the global neurodiagnostics market serves healthcare professionals by facilitating the diagnosis and monitoring of neurological disorders, driven by increasing disorder prevalence and the demand for precise diagnostic tools. While obstacles like costs and regulations persist, opportunities for technological innovations, remote monitoring, and research collaborations contribute to the market's growth and enhancement.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Neurodiagnostics and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to get the final quantitative and qualitative data.
Global Neurodiagnostics Market Segmental Analysis
The global neurodiagnostics market is segmented on the basis of condition, end user, and region. In terms of condition, the market is segmented into neuro degenerative diseases, epilepsy, stroke, headache disorders, sleep disorders, and others. With respect to categorization by end user, the market is segmented into hospitals & surgery centres, diagnostic laboratories & imaging centres, neurology centres, and others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Drivers of the Global Neurodiagnostics Market
The increasing occurrence of neurological disorders like Alzheimer's disease, Parkinson's disease, and epilepsy is a significant factor propelling the neurodiagnostics market forward. With aging populations and shifts in lifestyles worldwide, the incidence of neurological disorders is on the rise, consequently escalating the need for precise neurodiagnostic procedures for diagnosis and monitoring purposes.
The ongoing progress in neurodiagnostic equipment, including EEG machines, electromyography (EMG) devices, and neuroimaging tools, is fuelling market expansion. These technological advancements offer enhanced features, increased precision, and improved patient comfort. The presence of these advanced devices encourages healthcare providers to procure neurodiagnostic equipment, thus stimulating market growth.
Restraints in the Global Neurodiagnostics Market
The substantial expenses linked with neurodiagnostic procedures may impede market growth. These procedures typically entail costly equipment, specialized examinations, and skilled medical personnel. Such expenses could restrict access to these procedures, particularly in low- and middle-income nations, thus obstructing market expansion.
The neurodiagnostics sector must adhere to strict regulatory standards and compliance protocols. Securing regulatory clearance for novel neurodiagnostic devices and methods can be a lengthy and costly endeavor. These regulatory obstacles may impede innovation and the introduction of new products, presenting obstacles to market expansion.
Market Trends of the Global Neurodiagnostics Market
The incorporation of data analytics and cloud computing into neurodiagnostics is becoming increasingly popular. Storing and analyzing extensive patient data in the cloud allows for streamlined data management, remote collaboration, and the creation of predictive models to enhance diagnosis and treatment strategies. This shift encourages the use of data-driven approaches and personalized care in neurodiagnostics.
Table of Contents
- Executive Summary
- Market Overview
- Wheel of Fortune
- Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
- Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
- Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
- Market Dynamics
- Global Neurodiagnostics Market by Condition
- Market Overview
- Neuro Degenerative Diseases
- Epilepsy
- Stroke
- Headache Disorders
- Sleep Disorders
- and Others
- Global Neurodiagnostics Market by End User
- Market Overview
- Hospitals & Surgery Centers
- Diagnostic Laboratories & Imaging Centers
- Neurology Centers
- and Others
- Global Neurodiagnostics Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
- Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
- Key Company Profiles
- Siemens Healthineers (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GE Healthcare (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Philips Healthcare (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Medtronic (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Hitachi Medical Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Natus Medical Incorporated (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Abbott Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Koninklijke Philips N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Thermo Fisher Scientific Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Elekta AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Brainlab AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Masimo Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cadwell Industries Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Advanced Brain Monitoring, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Compumedics Limited (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Neurosoft Ltd. (Russia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Magstim (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- NeuroWave Systems Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- BrainScope Company Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Blackrock Microsystems LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Siemens Healthineers (Germany)
神經診斷與監測設備 - 全球市場考量、競爭格局、市場預測 (2030)
神經診斷市場報告：2030 年趨勢、預測與競爭分析
神經診斷·監測設備的開發平台 - 開發階段，市場區隔，地區和國家，法規途徑，主要企業(2023年版)
2030 年神經診斷市場預測：按產品、最終用戶按症狀和地區進行全球分析
2024-2028年神經診斷的全球市場
全球神經診斷學市場 - 2023-2030年
神經診斷市場：按產品、適應症和最終用戶分類 - 全球預測 2023-2030
神經診斷的全球市場
神經診斷市場 - COVID-19 的增長、趨勢、影響和預測 (2023-2028)